Clinical trial
Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic…
NCT00235885 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00235885 |
|---|---|
| Title | Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) |
| Official title | Safety and Efficacy of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) - An Open-Label, Multinational Study to Evaluate the Response to Every-Other Week Adalimumab When Added to Insufficient Standard Therapy, Including Patients Who Failed Prior Treatment With Other TNF-Inhibitors… |
| Acronym | STEREO |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriatic Arthritis |
| Intervention type | Drug |
| Interventions | adalimumab |
| Enrollment | 445 |
| Start date | Jul 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Aug 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: